MX2009008165A - Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos. - Google Patents
Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.Info
- Publication number
- MX2009008165A MX2009008165A MX2009008165A MX2009008165A MX2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A
- Authority
- MX
- Mexico
- Prior art keywords
- oxidative stress
- mammals
- decreasing inflammation
- mammal
- glucose
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 4
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000003247 decreasing effect Effects 0.000 title abstract 2
- 230000008798 inflammatory stress Effects 0.000 title abstract 2
- 230000036542 oxidative stress Effects 0.000 title abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 3
- 230000000340 anti-metabolite Effects 0.000 abstract 3
- 229940100197 antimetabolite Drugs 0.000 abstract 3
- 239000002256 antimetabolite Substances 0.000 abstract 3
- 239000008103 glucose Substances 0.000 abstract 3
- 108010053070 Glutathione Disulfide Proteins 0.000 abstract 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/42—Dry feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/48—Moist feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
Abstract
La presente invención está dirigida a un método para disminuir la inflamación y el estrés en un mamífero, que comprende; la administración de una composición que comprende un antimetabolito de glucosa a un mamífero; y en donde dicha composición comprende cantidades suficientes de antimetabolito de glucosa para disminuir un nivel de proteína C reactiva en la sangre del mamífero después de la administración del antimetabolito de glucosa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89885407P | 2007-02-01 | 2007-02-01 | |
PCT/IB2008/050381 WO2008093302A2 (en) | 2007-02-01 | 2008-01-31 | Method for decreasing inflammation and oxidative stress in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008165A true MX2009008165A (es) | 2009-08-12 |
Family
ID=39674579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008165A MX2009008165A (es) | 2007-02-01 | 2008-01-31 | Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080260696A1 (es) |
EP (1) | EP2124969A2 (es) |
JP (1) | JP2010516805A (es) |
CN (1) | CN102036670A (es) |
AR (1) | AR065146A1 (es) |
AU (1) | AU2008211599A1 (es) |
BR (1) | BRPI0808390A2 (es) |
CA (1) | CA2675510A1 (es) |
MX (1) | MX2009008165A (es) |
RU (1) | RU2429853C2 (es) |
WO (1) | WO2008093302A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US20090252834A1 (en) * | 2004-05-10 | 2009-10-08 | Michael Griffin Hayek | Compositions comprising glucose anti-metabolites |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
PL1885383T3 (pl) | 2005-05-31 | 2017-06-30 | Iams Europe B.V. | Kocie probiotyczne bifidobakterie |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US20120283197A1 (en) * | 2011-05-02 | 2012-11-08 | Ashok Premchand Luhadiya | Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT |
ES2698601T3 (es) * | 2013-05-23 | 2019-02-05 | Iams Europe B V | Imitación de los efectos metabólicos de las restricciones calóricas por administración de antimetabolitos de glucosa para mejorar la respuesta positiva en mamíferos |
KR101757164B1 (ko) * | 2015-11-24 | 2017-07-12 | 이화여자대학교 산학협력단 | 항산화 및 항염증 식품 소재의 중재 효과 예측 지표 대사체 |
JP2018039752A (ja) * | 2016-09-07 | 2018-03-15 | 花王株式会社 | Nrf2活性化剤 |
MX2021005374A (es) * | 2018-11-08 | 2021-09-14 | Dsm Ip Assets Bv | Metodos para dar soporte a homeostasis gastrointestinal. |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2641548A (en) * | 1950-04-06 | 1953-06-09 | Helen W Heinrich | Method of preserving avocados |
US3398001A (en) * | 1963-04-26 | 1968-08-20 | Air Reduction | Process of preparing and packaging frozen avocados |
US3677898A (en) * | 1969-01-31 | 1972-07-18 | Ajinomoto Kk | Acid protease and method of preparing the same |
US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
JPS6297221A (ja) * | 1985-10-22 | 1987-05-06 | ウチヤ・サ−モスタツト株式会社 | 可変型温度調節器 |
US4808626A (en) * | 1986-09-23 | 1989-02-28 | Monell Chemical Senses Center | Use of 2,5-anhydro-D-mannitol as a food intake modifier |
US4814193A (en) * | 1988-04-06 | 1989-03-21 | General Foods Corporation | Reduction of microbial population on surface of food materials |
US5126153A (en) * | 1988-05-13 | 1992-06-30 | Basic American Foods, Inc. | Compositions and methods for inhibiting browning of processed produce |
US5344824A (en) * | 1990-02-02 | 1994-09-06 | Matsutani Chemical Industries Co., Ltd. | Method for reducing insulin secretion |
US5871794A (en) * | 1996-08-07 | 1999-02-16 | Brito; Jorge Issac | Stabilized guacamole and method for making same |
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
US5939117A (en) * | 1997-08-11 | 1999-08-17 | Mantrose-Haeuser Co., Inc. | Methods for preserving fresh fruit and product thereof |
DE19860375A1 (de) * | 1998-12-28 | 2000-07-06 | Aventis Res & Tech Gmbh & Co | Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel |
US6358555B1 (en) * | 1999-03-31 | 2002-03-19 | Hideyuki Takahashi | Process for producing frozen avocados |
US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
ATE407689T1 (de) * | 2000-08-01 | 2008-09-15 | Oryza Oil & Fat Chem | Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess |
US6586027B2 (en) * | 2001-02-23 | 2003-07-01 | T.F.H. Publications, Inc. | Health chew toy |
EP1372614A4 (en) * | 2001-03-16 | 2007-10-31 | Andrx Pharmaceuticals Llc | SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE |
EP1277412A1 (en) * | 2001-07-17 | 2003-01-22 | Societe Des Produits Nestle S.A. | Pet food composition for regulating body weight and preventing obesity and related disorders in pets |
US7666459B2 (en) * | 2001-09-12 | 2010-02-23 | The Procter & Gamble Company | Pet food compositions |
US6896914B2 (en) * | 2001-10-26 | 2005-05-24 | David I. Chapnick | Method for normalizing insulin levels |
US6733795B2 (en) * | 2002-07-30 | 2004-05-11 | Laboratoires Expanscience | Method for producing an avocado leaf extract rich in furanic lipids |
ES2295624T3 (es) * | 2002-07-30 | 2008-04-16 | Laboratoires Expanscience | Procedimiento de obtencion de un extracto de hojas de aguacate rico en lipidos furanicos. |
DK1694137T3 (da) * | 2003-11-26 | 2009-04-27 | Hills Pet Nutrition Inc | Fremgangsm de til at reducere lugt af aff ring fra k ledyr |
FR2869543B1 (fr) * | 2004-04-30 | 2006-07-28 | Expanscience Laboratoires Sa | Medicament comprenant un extrait peptidique d'avocat destine au traitement et la prevention des maladies liees a une deficience du systeme immunitaire |
FR2869541B1 (fr) * | 2004-04-30 | 2007-12-28 | Expanscience Sa Lab | Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee |
US20050249837A1 (en) * | 2004-05-10 | 2005-11-10 | The Procter & Gamble Company | Processes for preparing plant matter extracts and pet food compositions |
KR20070034591A (ko) * | 2004-06-17 | 2007-03-28 | 위스콘신 얼럼나이 리서어치 화운데이션 | 발작 및 발작병을 치료하기 위한 화합물 및 방법 |
-
2008
- 2008-01-31 JP JP2009547797A patent/JP2010516805A/ja active Pending
- 2008-01-31 RU RU2009127333/15A patent/RU2429853C2/ru not_active IP Right Cessation
- 2008-01-31 CN CN2008800035145A patent/CN102036670A/zh active Pending
- 2008-01-31 WO PCT/IB2008/050381 patent/WO2008093302A2/en active Application Filing
- 2008-01-31 BR BRPI0808390-8A patent/BRPI0808390A2/pt not_active IP Right Cessation
- 2008-01-31 MX MX2009008165A patent/MX2009008165A/es not_active Application Discontinuation
- 2008-01-31 AU AU2008211599A patent/AU2008211599A1/en not_active Abandoned
- 2008-01-31 CA CA002675510A patent/CA2675510A1/en not_active Abandoned
- 2008-01-31 EP EP08702545A patent/EP2124969A2/en not_active Withdrawn
- 2008-02-01 US US12/012,318 patent/US20080260696A1/en not_active Abandoned
- 2008-02-01 AR ARP080100439A patent/AR065146A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008211599A1 (en) | 2008-08-07 |
BRPI0808390A2 (pt) | 2014-07-08 |
AR065146A1 (es) | 2009-05-20 |
WO2008093302A3 (en) | 2008-12-11 |
RU2429853C2 (ru) | 2011-09-27 |
WO2008093302A2 (en) | 2008-08-07 |
CA2675510A1 (en) | 2008-08-07 |
JP2010516805A (ja) | 2010-05-20 |
RU2009127333A (ru) | 2011-03-10 |
CN102036670A (zh) | 2011-04-27 |
US20080260696A1 (en) | 2008-10-23 |
EP2124969A2 (en) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008165A (es) | Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos. | |
MX2009008166A (es) | Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. | |
HRP20110969T1 (en) | Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure | |
PH12013501319A1 (en) | Fatty acid acetylated salicylates and their uses | |
WO2009134973A8 (en) | Quinolines and related analogs as sirtuin modulators | |
WO2010062863A3 (en) | Compositions containing satiogens and methods of use | |
CL2009000782A1 (es) | Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades. | |
AR059089A1 (es) | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal | |
MX2011006084A (es) | Isoindolinona y analogos relacionados como moduladores de sirtuina. | |
MX2010002734A (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva. | |
MX2011006475A (es) | Ftalazinona y analogos relacionados como moduladores de sirtuina. | |
WO2010042886A3 (en) | Pyrones for the treatment of metabolic disorders | |
MX2010000266A (es) | Un método para disminuir los síntomas del consumo de alcohol. | |
BRPI0717458A8 (pt) | Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
MX2010006650A (es) | Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica. | |
WO2008147483A8 (en) | Neurogenic compounds | |
WO2005097187A3 (en) | Methods of preventing uvb-induced skin damage | |
WO2006049657A3 (en) | Insulin secretion by anthocyanins and anthocyanidins | |
MX355388B (es) | Composiciones farmaceuticas y metodos terapeuticos que emplean una combinacion de un compuesto complejo de manganeso y una forma compleja no de manganeso del compuesto. | |
WO2010021750A3 (en) | Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer | |
WO2008129851A1 (ja) | 一酸化窒素合成酵素活性化剤 | |
ATE533482T1 (de) | Verfahren zur gewichtsreduktion | |
WO2008139313A8 (es) | Solución anestésica transparente de propofolol, con baja irritación venosa | |
NZ621994A (en) | Transdermal venous access locking solutions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |